Asia · Markets & Finance · CNBC-TV18

Sun Pharmaceutical board to consider ₹15,000 crore NCD issue on October 12

Published by CNBC-TV18 · India 3 h ago

Sun Pharma’s board will consider an NCD issue of up to ₹15,000 crore on October 12. The debentures are proposed to be issued through private placement in one or more tranches.

Read the full article on CNBC-TV18 Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.cnbctv18.com)

Also worth reading

Business Standard

Sebi brings risk-o-meter for debt securities; eases norms for debt-raising

The Economic Times

Lightning hits IndiGo flight; all 110 onboard safe

The Straits Times Business

SingPost trials digital stamps to make mailing letters ‘as seamless as sending a message’

SCMP Business

Hong Kong tech index to harness fast-growth companies in bid for better performance

Moneycontrol

Varun Dhawan becomes investor in Shark Tank India brand Better Nutrition after buying a farm, says ‘This is quite personal for me’

The Edge Singapore